Cancer immunotherapy using virus particles
AssigneeCase Western Reserve University
InventorsNicole F. Steinmetz, Karin L. Lee
Life of this patent
Estimating the term…
Abstract
A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.
Claims20
A method of treating cancer in a subject in need thereof, comprising administering directly to the cancer a therapeutically effective amount of an in situ vaccine, the in situ vaccine including at least one of potato virus X (PVX) or PVX virus-like particles, and an anti-cancer agent, wherein the PVX or PVX virus-like particles are not used as a vehicle for drug or antigen delivery.
A method of treating cancer in a subject in need thereof, comprising administering to the subject therapeutically effective amounts of an anti-cancer agent and an in situ vaccine, wherein the in situ vaccine includes at least one of potato virus X (PVX) or virus-like particles, the PVX or PVX virus like particles and the anti-cancer agent are administered directly to the cancer, and wherein the PVX or PVX virus-like particles are not used as a vehicle for drug or antigen delivery.
Dependencies are inferred from the claim text.